Showing results (581-590 of 1,837) with videos related to
Sort By:
Pageof 184
ESMO Open|April 5, 2025
131I-mIBG therapy in relapsed/refractory neuroblastoma: an old bridge to the futureM A De Ioris, M F Villani, F Fabozzi, et al.ESMO Open|May 23, 2025
Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancerD S Hong, R-H Xu, L Shen, et al.ESMO Open|May 24, 2025
Health-related quality-of-life profile and clinical outcomes in first-line advanced renal cell carcinoma: a modeling analysis based on the CheckMate 9ER studyD Cella, M Derosa, L Floden, et al.ESMO Open|May 16, 2025
Causal analyses of the impact of comorbid conditions and concomitant medications on response to neoadjuvant chemotherapy in breast cancer: analysis of a multicenter prospective cohort study (CANTO)A-S Hamy, B Grandal, F Jochum, et al.ESMO Open|May 16, 2025
Impact of extending the original criteria in the Chemoradiotherapy for Oesophageal Cancer followed by Surgery Study (CROSS) regimen on treatment outcome in locally advanced esophageal cancer patientsH H Wang, I M Nolte, R H A Verhoeven, et al.ESMO Open|May 20, 2025
HR-SC-an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparibL Beltrame, L Mannarino, A Sergi, et al.ESMO Open|May 15, 2025
Multi-assistant methods improve stromal tumor-infiltrating lymphocytes (sTILs) assessment in breast cancer: results of multi-institutional ring studiesM Zhao, P Dong, Z Li, et al.ESMO Open|May 7, 2025
Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiativeJ Taieb, J Seligmann, D Modest, et al.ESMO Open|April 1, 2025
Prognosis, clinicopathological characteristics, and treatment patterns of patients with ER-intermediate-positive breast cancer undergoing long-term follow-upN Matsumoto, Y Wanifuchi-Endo, T Fujita, et al.ESMO Open|March 26, 2025
Pan-cancer clinical and molecular landscape of MTAP deletion in nationwide and international comprehensive genomic dataH Ikushima, K Watanabe, A Shinozaki-Ushiku, et al.Pageof 184